European Commission logo
English English
CORDIS - EU research results
CORDIS

In vitro model of Fragile X Syndrome using naïve iPSCs

Project description

In vitro model of Fragile X syndrome

Fragile X syndrome (FXS) is a rare genetic developmental disorder associated with cognitive impairment and learning disabilities. It is caused by a mutation in the Fragile X mental retardation one (FMR1) gene, which leads to diminished expression of the FMRP protein, a necessary component of synapse development. The timing of FMR1 silencing is unknown as there are no available models of the disease. To address this problem, the EU-funded NeuroStemX project is developing FXS neurons from patient-derived induced pluripotent stem cells (iPSCs). The iPSC-based model will be utilised to study the onset of FMR1 silencing during neural development as well as the associated neuronal defects in FXS patients.

Objective

Neurological and mental disorders are top priorities for the European Commission, which actively invests in research aimed at better understanding brain function and dysfunction, and at finding new therapies for brain disorders. Fragile X syndrome (FXS) is the major monogenetic cause for intellectual disability and is frequently associated with autism spectrum disorder. The trinucleotide repeat expansion, methylation and epigenetic silencing of fragile mental retardation 1 (FMR1) gene promoter leads to the loss of the corresponding protein. However, the molecular mechanism and the timing leading to FMR1 silencing are still unknown due to the absence of reliable in vivo and in vitro models. The recent development of naïve PSCs showing a broader unmethylated genome (including in FMR1) opened a new hope for disease modeling of FXS, but data are still partial and contradictory. The NeuroStemX project aims at filling this gap taking advantage of an optimized technique for the generation of naïve iPSCs developed at the University of Padova (UniPd) and generation of FXS neurons with various approaches mastered by the Experienced Researcher (ER) in conjunction with the microtechnologies developed by UniPd. In particular, we aim at 1) identifying the timing of FMRP silencing during neural development using naïve iPSCs and 2) establishing a reliable in vitro system to model neuronal defects observed in FXS patients. In this project, we are addressing some of the most crucial problems related with FXS pathogenesis and modeling using a variety of innovative approaches. This will give the ER an outstanding training-through-research opportunity by means of a personalized multidisciplinary project, in which the ER will enlarge her scientific competences and strengthen her professional profile. The training includes both scientific and transferable skills, aimed at the reinforcement of the ER professional maturity and independence.

Coordinator

UNIVERSITA DEGLI STUDI DI PADOVA
Net EU contribution
€ 183 473,28
Address
VIA 8 FEBBRAIO 2
35122 Padova
Italy

See on map

Region
Nord-Est Veneto Padova
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 183 473,28